How Does Cortexyme Inc (CRTX) Stock Rank on Wall Street Tuesday?

Tuesday, June 14, 2022 03:18 PM | InvestorsObserver Analysts

Mentioned in this article

How Does Cortexyme Inc (CRTX) Stock Rank on Wall Street Tuesday?

Wall Street is neutral on Cortexyme Inc (CRTX). On average, analysts give the stock a Buy rating. The average price target is $10.333, which means analysts expect the stock to increase by 274.38% over the next twelve months. That average ranking earns the stock an Analyst Rating of 12, which is better than 12% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating CRTX a Buy today. Find out what this means to you and get the rest of the rankings on CRTX!

See Full CRTX Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Cortexyme Inc Stock Today?

Cortexyme Inc (CRTX) stock is higher by 1.66% while the S&P 500 is down -1.1% as of 2:59 PM on Tuesday, Jun 14. CRTX is up $0.05 from the previous closing price of $2.71 on volume of 115,886 shares. Over the past year the S&P 500 is down -12.85% while CRTX is down -94.20%. CRTX lost -$2.96 per share the over the last 12 months. Click Here to get the full Stock Report for Cortexyme Inc stock.